[go: up one dir, main page]

WO1998017231A3 - Traitement et administration d'hydroxychloroquine - Google Patents

Traitement et administration d'hydroxychloroquine Download PDF

Info

Publication number
WO1998017231A3
WO1998017231A3 PCT/US1997/019170 US9719170W WO9817231A3 WO 1998017231 A3 WO1998017231 A3 WO 1998017231A3 US 9719170 W US9719170 W US 9719170W WO 9817231 A3 WO9817231 A3 WO 9817231A3
Authority
WO
WIPO (PCT)
Prior art keywords
hydroxychloroquine
treatment
delivery
disease states
various disease
Prior art date
Application number
PCT/US1997/019170
Other languages
English (en)
Other versions
WO1998017231A2 (fr
Inventor
B Lauren Charous
Original Assignee
B Lauren Charous
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by B Lauren Charous filed Critical B Lauren Charous
Publication of WO1998017231A2 publication Critical patent/WO1998017231A2/fr
Publication of WO1998017231A3 publication Critical patent/WO1998017231A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne le traitement par l'hydroxychloroquine de différents états pathologiques.
PCT/US1997/019170 1996-10-18 1997-10-17 Traitement et administration d'hydroxychloroquine WO1998017231A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2863896P 1996-10-18 1996-10-18
US60/028,638 1996-10-18

Publications (2)

Publication Number Publication Date
WO1998017231A2 WO1998017231A2 (fr) 1998-04-30
WO1998017231A3 true WO1998017231A3 (fr) 1998-10-08

Family

ID=21844595

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/019170 WO1998017231A2 (fr) 1996-10-18 1997-10-17 Traitement et administration d'hydroxychloroquine

Country Status (1)

Country Link
WO (1) WO1998017231A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1175216A2 (fr) 1999-04-30 2002-01-30 APT Pharmaceutical, L.L.C. Agents antipaludeens pour le traitement de l'asthme
IL310969A (en) * 2015-06-30 2024-04-01 Eiger Group Int Inc Use of chloroquine and clemizole compounds for treatment of inflammatory and cancerous conditions

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4181725A (en) * 1977-05-02 1980-01-01 The Regents Of The University Of Michigan Method for alleviating psoriasis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4181725A (en) * 1977-05-02 1980-01-01 The Regents Of The University Of Michigan Method for alleviating psoriasis

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
CHAROUS B.L., "Effectiveness of Long-Term Treatment of Severe Asthma with Hydroxychloroquine (HCQ)", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1991, Vol. 629, pages 432-433. *
CHAROUS B.L., "Open Study of Hydroxychloroquine in the Treatment of Severe Symptomatic or Corticosteroid-Dependent Asthma", ANNALS OF ALLERGY, July 1990, Vol. 65, No. 1, pages 53-58. *
COCKCROFT D.W., "Therapy for Airway Inflammation in Asthma", J. ALLERGY CLIN. IMMUNOL., May 1991, Vol. 87, No. 5, pages 914-919. *
FOX et al., "Treatment of Primary Sjogren's Syndrome with Hydroxychloroquine", THE AMERICAN JOURNAL OF MEDICINE, 14 October 1988, Vol. 85 (Suppl. 4A), pages 62-67. *
SEGGEV J.S., "Inhibition of IL-4-Driven IgE Synthesis by Peripheral Blood Lymphocytes (PBL) In Vitro with hydroxychloroquine (HCQ)", J. IMMUNOL., Abstract No. 343, 1993, Vol. 158, No. 8, page 62A. *
SHERMAN et al., "Short-Term Effects of Hydroxychloroquine (HCQ) on IgE Levels and Obstructive Airways Disease", J. ALLERGY CLIN. IMMUNOL., Abstract No. 265, January 1992, Vol. 89, No. 1:2, page 286. *

Also Published As

Publication number Publication date
WO1998017231A2 (fr) 1998-04-30

Similar Documents

Publication Publication Date Title
AU3955795A (en) Biocompatible coating, medical device using the same and methods
ZA971259B (en) Antimicrobial peptides and methods of use.
EP0617092A3 (fr) Revêtement diffusant la lumière, préparation et usage.
AU3176297A (en) Substituted 7-amino-pyrrolo{3,2-d}pyrimidines and the use thereof
AU7693396A (en) Poly(9,9'-spiro-bisfluorenes), the production and use of same
AU3802097A (en) Aroma therapy diffuser
AU5772296A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU3725997A (en) S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders
AU5772396A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU3480297A (en) Modified mcm-56, its preparation and use
AU4479997A (en) Sustained delivery device and methods of making and using the same
AU1281599A (en) Quiet and smooth, positive acting, no-slip differential
AU6636598A (en) Novel 3,4-dialkoxyphenyl derivatives and the use thereof
ZA97741B (en) Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders.
AU2418499A (en) Org-5222 in the treatment of depression
AU7274598A (en) Light delivery catheter and method for the use thereof
AU3759099A (en) Diffusing imager and associated methods
AU7624598A (en) 1,4-diazabicyclo (2.2.2) Oct-2-ylmethyl derivatives, their preparation and the rapeutic application
AU1588497A (en) The extract of pine needle and the use thereof
ZA973843B (en) Treatment of asthma with TNFR-lg.
ZA963462B (en) Polyurethane-polyureas and their use as emulsifiers.
WO1998017231A3 (fr) Traitement et administration d'hydroxychloroquine
AU3576495A (en) Games, puzzles and the like
ZA9711047B (en) Formulation and use.
AU7493496A (en) Fluoropropenyl oxadiazoles and the use thereof as pest control agents

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA